Michael Karin is a distinguished scientist who has made significant impact in biology and medical research. Michael Karin obtained his Bachelor of Science degree in Biology from Tel Aviv University in 1975, and subsequently a Ph.D. in Molecular Biology from the University of California, Los Angeles in 1979. He has been the Distinguished Professor of Pharmacology and Pathology at the University of California San Diego School of Medicine since 1986. Michael Karin is an Elected Member of the US National Academy of Sciences, the National Academy of Medicine, the American Association for Cancer Research Academy and the European Molecular Biology Organization. This underscores the immense respect and recognition he has garnered in the scientific community.

Michael Karin's transformative impact on the field is evident through his authorship of over 300 papers, with more than 100 of these in elite journals such as Nature, Science, and Cell. The significance of his research is underscored by over 300,000 citations, and a h-index of 275. At the core of Michael Karin's research is an exploration of the intricate relationship between inflammation, cancer and metabolic diseases. His work has unveiled critical signal transduction pathways, illuminating the molecular mechanisms underlying these health issues. His research has contributed to cancer prevention, therapy, and the treatment of non-alcoholic steatohepatitis (NASH).